Attempt to assess direct interactions between tumor burden, myeloid-derived suppressor cells and PD-1- and TIM-3-expressing T cells in multiple myeloma patients

Author:

Batorov E. V.1ORCID,Aristova T. A.2ORCID,Pronkina N. V.2,Denisova V. V.2ORCID,Sizikova S. A.2ORCID,Ushakova G. Yu.2ORCID

Affiliation:

1. Research Institute of Fundamental and Clinical Immunology; V. Zelman Institute of Medicine and Psychology, Novosibirsk National Research State University

2. Research Institute of Fundamental and Clinical Immunology

Abstract

The avoidance of immune surveillance by malignant plasma cells (PCs) in multiple myeloma (MM) is mediated by different mechanisms, among which an induction of T cell exhaustion and expansion of myeloid-derived suppressor cells (MDSCs) appear to play substantial roles, but it is still a lack of data on possible MDSC-mediated induction of T cell exhaustion. The aim of the present work was to evaluate possible relationship between frequencies of MM PCs, MDSCs and phenotypically exhausted PD-1+ and TIM-3+ T cells in bone marrow (BM) samples and peripheral blood (PB) of MM patients at various disease stages. Peripheral blood (n = 88) and BM samples (n = 56) were obtained from MM patients (newly diagnosed (n = 6), patients in remission (n = 71) and with progressive disease (n = 11)). Frequencies of T cells expressing checkpoint receptors PD-1 and TIM-3, polymorphonuclear MDSCs (PMN-MDSCs, Lin-CD14-HLA-DR- CD33+CD15+/CD66b+), monocyte MDSCs (M-MDSCs, CD14+HLA-DRlow/-), early MDSCs (E-MDSCs, Lin-HLA-DR-CD33+CD15-/CD66b-), and MM PCs (CD45dimCD38+CD138+CD56+CD19-CD117+CD27- CD81-) were assessed with flow cytometry. Circulating and BM-resident PD-1+/TIM-3+T cell subsets, BM E-MDSCs, as soon as MM PCs and serum beta2-microglobulin (B2-M) levels were gradually increased in patients at different stages. Despite that, there were no associations between the markers of tumor load and the studied cell subsets. In patients in remission, BM PMN-MDSCs negatively correlated with CD4+T cells, CD4+PD-1+ and CD8+TIM-3+T cell subsets; there were positive correlations between BM E-MDSCs and CD4+PD-1+TIM-3+ cells and PB M-MDSCs and CD8+PD-1+ and (as a trend) CD8+TIM-3+T cells. We found no associations for the samples of patients at diagnosis and with progression. We can conclude that a possible mutual influence of malignant PCs, MDSCs and PD-1+/TIM-3+T cells is nonlinear, especially during a manifest tumor growth at diagnosis and progression. The detected negative correlations between resident PMN- MDSCs and T cell subsets might be associated with MDSC suppressive function, affecting both predominantly activated PD-1+ cells and exhausted TIM-3+ subsets. The positive correlations between BM E-MDSCs and CD4+PD-1+TIM-3+ cell subset and circulating M-MDSCs and PD-1+ and TIM-3+ CD8+T cells might confirm an ability of MDSCs to induce T cell exhaustion.

Publisher

SPb RAACI

Subject

Immunology,Immunology and Allergy

Reference15 articles.

1. Atanackovic D., Luetkens T., Radhakrishnan S., Kroger N. Coinhibitory molecule PD-1 as a therapeutic target in the microenvironment of multiple myeloma. Curr. Cancer Drug Targets, 2017, Vol. 17, no. 9, pp. 839-845.

2. Batorov E.V., Aristova T.A., Sergeevicheva V.V., Sizikova S.A., Ushakova G.Y., Pronkina N.V., Shishkova I.V., Shevela E.Y., Ostanin A.A., Chernykh E.R. Quantitative and functional characteristics of circulating and bone marrow PD-1- and TIM-3-positive T cells in treated multiple myeloma patients. Sci. Rep., 2020, Vol. 10, 20846. doi: 10.1038/s41598-020-77941-y.

3. Chang Y., Jiang Y., Chen Y., Xing X., Zhou Y., Sang T., Li J., Zhao A., Zhang J., Zhao J., Liu Y., Zheng C. Bone marrow PD-1 positive T cells reflect tumor mass and prognosis in multiple myeloma. Int. J. Clin. Exp. Pathol., 2018, Vol. 11, no. 1, pp. 304-313.

4. Christiansson L., Soderlund S., Svensson E., Mustjoki S., Bengtsson M., Simonsson B., Olsson-Stromberg U., Loskog A.S.I. Increased level of myeloid-derived suppressor cells, programmed death receptor ligand 1/programmed death receptor 1, and soluble CD25 in Sokal high risk chronic myeloid leukemia. PLoS One, 2013, Vol. 8, e55818. doi: 10.1371/journal.pone.0055818.

5. de Veirman K., van Valckenborgh E., Lahmar Q., Geeraerts X., de Bruyne E., Menu E., van Riet I., Vanderkerken K., van Ginderachter J.A. Myeloid-derived suppressor cells as therapeutic target in hematological malignancies. Front. Oncol., 2014, Vol. 4, 349. doi: 10.3389/fonc.2014.00349.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3